loadpatents
name:-0.035683870315552
name:-0.27099585533142
name:-0.0025889873504639
Max Delbruck-Centrum fur Molekulare Medizin Patent Filings

Max Delbruck-Centrum fur Molekulare Medizin

Patent Applications and Registrations

Patent applications and USPTO patent grants for Max Delbruck-Centrum fur Molekulare Medizin.The latest application filed is for "analogs of cyp-eicosanoids for use in treating or preventing a disorder associated with neovascularization and/or inflammation".

Company Profile
1.31.32
  • Max Delbruck-Centrum fur Molekulare Medizin - Berlin DE
  • Max-Delbruck-Centrum fur Molekulare Medizin - Berlin-Buch DE
  • Max-Delbruck-Centrum Fur Molekulare Medizin -
  • Max-Delbruck-Centrum fur Molekulare Medizin - DE DE
  • Max-Delbruck-Centrum fur molekulare Medizin - Robert-Rossle-Strasse 10 Berlin DE
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Analogs of CYP-Eicosanoids for Use in Treating or Preventing a Disorder Associated with Neovascularization and/or Inflammation
App 20210353569 - Fischer; Robert ;   et al.
2021-11-18
Metabolically robust analogs of CYP-eicosanoids for the treatment of cardiac disease
Grant 11,096,910 - Fischer , et al. August 24, 2
2021-08-24
Xanthine derivatives, their use as a medicament, and pharmaceutical preparations comprising the same
Grant 11,028,104 - Bader , et al. June 8, 2
2021-06-08
Xanthine Derivatives, Their Use As A Medicament, And Pharmaceutical Preparations Comprising The Same
App 20200262847 - BADER; Michael ;   et al.
2020-08-20
Antibody that binds CD269 (BCMA) suitable for use in the treatment of plasma cell diseases such as multiple myeloma and autoimmune diseases
Grant 10,745,486 - Lipp , et al. A
2020-08-18
Xanthine derivatives, their use as a medicament, and pharmaceutical preparations comprising the same
Grant 10,683,309 - Bader , et al.
2020-06-16
Replicative Transposon System
App 20190323037 - BUERCKSTUEMMER; Tilmann ;   et al.
2019-10-24
Xanthine Derivatives, Their Use As A Medicament, And Pharmaceutical Preparations Comprising The Same
App 20190161503 - BADER; Michael ;   et al.
2019-05-30
Metabolically Robust Analogs Of Cyp-eicosanoids For The Treatment Of Cardiac Disease
App 20190133976 - FISCHER; Robert ;   et al.
2019-05-09
Analogs Of Cyp-eicosanoids For Use In Treating Or Preventing A Disorder Associated With Neovascularization And/or Inflammation
App 20190117597 - FISCHER; Robert ;   et al.
2019-04-25
Antibody That Binds Cd269 (bcma) Suitable For Use In The Treatment Of Plasma Cell Diseases Such As Multiple Myeloma And Autoimmune Diseases
App 20190106499 - Lipp; Martin ;   et al.
2019-04-11
Xanthine derivatives, their use as a medicament, and pharmaceutical preparations comprising the same
Grant 10,214,530 - Bader , et al. Feb
2019-02-26
Antibody that binds CD269 (BCMA) suitable for use in the treatment of plasma cell diseases such as multiple myeloma and autoimmune diseases
Grant 10,189,906 - Lipp , et al. Ja
2019-01-29
Hyperactive Variants of the Transposase Protein of the Transposon System Sleeping Beauty
App 20180135032 - Izsvak; Zsuzsanna ;   et al.
2018-05-17
Xanthine Derivatives, Their Use As A Medicament, And Pharmaceutical Preparations Comprising The Same
App 20180051025 - BADER; Michael ;   et al.
2018-02-22
Nucleic acids encoding SB10 variants
Grant 9,840,696 - Izsvak , et al. December 12, 2
2017-12-12
Novel Cyp-eicosanoid Derivatives
App 20170008918 - Schunck; Wolf-Hagen ;   et al.
2017-01-12
Enhancers of protein degradation
Grant 9,512,066 - Wanker , et al. December 6, 2
2016-12-06
Multiple Target T Cell Receptor
App 20160222080 - KIEBACK; Elisa ;   et al.
2016-08-04
Psoralen Derivatives For Preventing Or Treating Heart Failure Or Cardiac Hypertrophy
App 20160008339 - KLUSSMANN; Enno ;   et al.
2016-01-14
Polypeptide variants of sleeping beauty transposase
Grant 9,228,180 - Izsvak , et al. January 5, 2
2016-01-05
Antibody That Binds Cd269 (bcma) Suitable For Use In The Treatment Of Plasma Cell Diseases Such As Multiple Myeloma And Autoimmune Diseases
App 20150284467 - Lipp; Martin ;   et al.
2015-10-08
Peptides regulating the surface expression of the T cell receptor
Grant 9,085,641 - Schmetzer , et al. July 21, 2
2015-07-21
Use Of Aptamers In Therapy And/or Diagnosis Of Autoimmune Diseases
App 20140155466 - Schimke; Ingolf ;   et al.
2014-06-05
Pharmaceutical and diagnostic compositions for use in the treatment and diagnosis of neurodegenerative diseases or amyloid diseases
Grant 8,710,088 - Wanker , et al. April 29, 2
2014-04-29
Method for modulating, treating and/or preventing metabolic syndrome using MAS-G-protein-coupled receptor agonists
Grant 8,586,054 - Souza Dos Santos , et al. November 19, 2
2013-11-19
Enhancers of Protein Degradation
App 20120282629 - Wanker; Erich ;   et al.
2012-11-08
Polynucleotides For Medical Use
App 20120277281 - Mathas; Stephan ;   et al.
2012-11-01
Polynucleotides For Use In Medicine
App 20120277282 - Gotthardt; Michael ;   et al.
2012-11-01
Multiple Target T Cell Receptor
App 20110189141 - Kieback; Elisa ;   et al.
2011-08-04
Reconstructed human mariner transposon capable of stable gene transfer into chromosomes in vertebrates
Grant 7,951,927 - Miskey , et al. May 31, 2
2011-05-31
Hyperactive Variants Of The Transposase Protein Of The Transposon System Sleeping Beauty
App 20110117072 - Izsvak; Zsuzsanna ;   et al.
2011-05-19
Shp-2 inhibitors and pharmaceutical compositions comprising them
Grant 7,868,185 - Hellmuth , et al. January 11, 2
2011-01-11
Peptides Regulating The Surface Expression Of The T Cell Receptor
App 20100291120 - Schmetzer; Oliver ;   et al.
2010-11-18
Peptides of the AT.sub.1 receptor and their uses
Grant 7,745,139 - Wallukat , et al. June 29, 2
2010-06-29
Use Of Pol Iii Promoters For Controlled Expression Of Therapeutic Proteins
App 20100160416 - Charo; Jehad ;   et al.
2010-06-24
Therapy And Use Of Compounds In Therapy
App 20090197851 - Anker; Stefan ;   et al.
2009-08-06
Implantable active ingredient depot
Grant 7,556,827 - Reszka , et al. July 7, 2
2009-07-07
Agent for gene transfer
Grant 7,462,703 - Reszka , et al. December 9, 2
2008-12-09
Tumor vaccines for MUC1-positive carcinomas
Grant 7,342,094 - Karsten , et al. March 11, 2
2008-03-11
Use of the human LRP/MVP promotor for a vector that can be induced by therapy
Grant 7,297,535 - Stein , et al. November 20, 2
2007-11-20
Agents for treating human illnesses based on .beta.-catenin, and the production and use thereof
Grant 7,067,474 - Birchmeier , et al. June 27, 2
2006-06-27
Agent for medicamentous treatment of acute and chronic pain
App 20060110332 - Lewin; Gary ;   et al.
2006-05-25
Compressed air inhaler for pulmonary application of liposomal powder aerosols and powder aerosols
App 20050196345 - Diederichs, Julia Eva ;   et al.
2005-09-08
Method for improving transfection efficiency
Grant 6,881,577 - Cartier , et al. April 19, 2
2005-04-19
Collagenase 3 as a prognostic marker for rheumatoid arthritis
Grant 6,756,197 - Wernicke , et al. June 29, 2
2004-06-29
Vector system used in screening active substances
App 20040101888 - Calkhoven, Cornelis ;   et al.
2004-05-27
Mapkap kinase 2-inhibitors and the use thereof in anti-inflammatory therapy
Grant 6,683,172 - Kotlyarov , et al. January 27, 2
2004-01-27
Agents for the prevention of organ damage induced by therapeutic agents
App 20030202974 - Willnow, Thomas
2003-10-30
Unilamellar liposomal preparations with high active substance content
Grant 6,399,094 - Brandl , et al. June 4, 2
2002-06-04
Novel cationic amphiphiles for liposomal gene transfer
App 20020007073 - Schneider, Manfred ;   et al.
2002-01-17
Chimeric oligonucleotides and the use thereof
App 20010039263 - Matthes, Eckart ;   et al.
2001-11-08
Anti-tumoral therapy agent containing a contrast agent
Grant 6,207,133 - Reszka , et al. March 27, 2
2001-03-27
DNA sequences for matrix metalloproteases, their production and use
Grant 6,114,159 - Will , et al. September 5, 2
2000-09-05

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed